Hector Casab

Hector Casab has extensive experience in finance and leadership roles in the biopharmaceutical industry. Hector is currently the VP Finance at Lyell Immunopharma since March 2021. Hector has also served as the CFO at Alessa Therapeutics, Inc. from September 2018 to March 2021. Prior to that, they were the CFO/Vice President Finance and Administration at ForSight VISION5 in 2015 and the Vice President of Finance at Icon Bioscience, Inc. in 2014.

In terms of their leadership roles, Hector Casab has served as the President and Board Chair of The Association of Bioscience Financial Officers International, starting in December 2022. Hector was also a board member at The Association of Bioscience Financial Officers from 2014 to 2022. Additionally, they have contributed to the biopharmaceutical industry as a Band Member at Band of Angels and a Founder, Director, and CEO at Benjamin Links Foundation. Hector has also served as a board member at School-Force, the Belmont-Redwood Shores Public School Foundation from November 2018 to June 2022. Hector Casab is the CEO of Casab Partners, LLC since 2009. Overall, their work experience showcases their expertise in finance, leadership, and strategic management in the biopharmaceutical industry.

Hector Casab completed their MBA in Finance and Marketing from Santa Clara University from 1994 to 1997. Their education history also includes attending Oakland University, although specific details such as start and end years, degree name, and field of study are not provided.